TANAKA CAPITAL MANAGEMENT INC

CIK: 0000816788Latest portfolio: $54.8M · Q4 2025

Holdings

44

Total Value

$54.8M

New Positions

0

Closed Positions

0

#StockSharesValue% PortfolioChangeType
1
NUVBNuvation Bio Inc.
841,605$7.5M13.76%+157K
2
NVDANvidia
24,810$4.6M8.44%-69
3
NXENexGen Energy
442,625$4.1M7.43%
4
HTDCorcept Therapeutics
111,084$3.9M7.05%-125
5
AAPLApple Computing
12,937$3.5M6.42%-35
6
USOUnited States Antimony
615,975$3.1M5.64%-211,060
7
CPRXCatalyst Pharmaceuticals
114,418$2.7M4.87%
8
SYMSymbotic
43,354$2.6M4.71%-100
9
AUGOAura Minerals, Inc.
44,835$2.3M4.12%+13K
10
AFLAFLAC Inc.
20,369$2.2M4.09%
11
ONTOOnto Innovation
12,833$2.0M3.70%
12
ELVAElectrovaya
253,930$2.0M3.66%
13
AMATApplied Materials
6,988$1.8M3.31%-35
14
CGThe Carlyle Group
28,791$1.7M3.10%-50
15
SFStifel Financial Corp.
12,728$1.6M2.91%-75
16
CCOCameco
16,390$1.5M2.74%-115
17
QCOMQUALCOMM
7,742$1.3M2.42%-30
18
AMZNAmazon.com Inc.
5,042$1.2M2.12%-10
19
4I1Philip Morris International
6,336$1.0M1.85%-10
20
U6ZUranium Energy Corp.
77,051$900K1.64%
21
IJRIntellia Therapeutics
94,750$852K1.55%+95K
22
MAMastercard
1,201$686K1.25%
23
METAMeta Platforms
809$534K0.97%-10
24
PEPPepsiCo, Inc.
2,945$423K0.77%
25
ASMLASML Holding N V ADR
224$240K0.44%

Sector Breakdown

Financial Services0.0% ($3.8662242170215946e+26T)
Technology0.0% ($4.6273517309220267e+21T)
Healthcare0.0% ($754.1T)
Consumer Defensive0.0% ($4.2T)
Industrials0.0% ($2.6T)
Unknown0.0% ($10.2B)
Communication Services0.0% ($1.5B)
Energy0.0% ($4.1M)
Basic Materials0.0% ($2.3M)
Consumer Cyclical0.0% ($1.2M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$54.8M45
Q3 2025Nov 14, 2025$55.5M45
Q1 2025May 15, 2025$42.0M42
Q4 2024Feb 14, 2025$43.7M44

Fund Information

CIK0000816788
Most Recent FilingFeb 17, 2026
Number of Filings4

TANAKA CAPITAL MANAGEMENT INC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $54.8M across 44 holdings. The largest position is Nuvation Bio Inc. (NUVB), representing 13.8% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.